Ganciclovir Sodium API (CAS No. 107910-75-8) is the sodium salt form of Ganciclovir, an antiviral nucleoside analogue associated with cytomegalovirus (CMV) pharmaceutical applications. Ganciclovir belongs to the class of acyclic guanine nucleoside analogues and is associated with inhibition of viral DNA replication.
Following intracellular phosphorylation, Ganciclovir is converted to its pharmacologically active triphosphate form. Ganciclovir triphosphate inhibits viral DNA polymerase and interferes with viral DNA synthesis, thereby reducing replication of susceptible cytomegalovirus.
The sodium salt form is particularly relevant to parenteral and injectable pharmaceutical development. Pharmaceutical companies sourcing Ganciclovir Sodium API commonly evaluate assay, HPLC purity, sodium identity, related substances, process-related impurities, degradation products, residual solvents, water content, pH, solubility, and batch-to-batch consistency.
Salt-form identity and ionic composition are important quality considerations during Ganciclovir Sodium API qualification. Pharmaceutical buyers may evaluate sodium identification, chromatographic purity, related substances, water content, solution characteristics, and consistency of the impurity profile according to the approved product specification.
Ganciclovir Sodium is more suitable for aqueous pharmaceutical processing than the free Ganciclovir base because salt formation supports preparation of aqueous injectable formulations under controlled formulation conditions.
Swapnroop Drugs and Pharmaceuticals supplies Ganciclovir Sodium API for qualified pharmaceutical research, injectable formulation development, analytical, generic drug development, and regulated manufacturing requirements with product-specific quality documentation, pharmaceutical-grade packaging, and reliable supply-chain coordination. Key Features
Ganciclovir Sodium API is primarily associated with:
Ganciclovir Sodium is particularly associated with parenteral and intravenous Ganciclovir pharmaceutical products.
Ganciclovir Sodium is associated with injectable antiviral pharmaceutical development for cytomegalovirus-related applications.
Pharmaceutical formulation companies evaluating Ganciclovir Sodium API may review:
Product-specific API specifications should be evaluated according to the intended injectable dosage form, formulation process, target regulatory market, and approved pharmaceutical development requirements.
Ganciclovir Sodium is a pharmaceutical salt form associated with Ganciclovir-based antiviral products.
The antiviral activity is attributable to Ganciclovir following intracellular activation through phosphorylation. The resulting Ganciclovir triphosphate inhibits viral DNA polymerase and interferes with viral DNA synthesis.
Pharmaceutical companies developing Ganciclovir Sodium formulations may evaluate API purity, salt-form identity, impurity profile, solution characteristics, and formulation compatibility to support consistent drug-product manufacturing.
Ganciclovir and Ganciclovir Sodium should be treated as separate chemical material identities.
Ganciclovir free compound has CAS No. 82410-32-0, molecular formula C9H13N5O4, and molecular weight 255.23 g/mol.
Ganciclovir Sodium has CAS No. 107910-75-8, molecular formula C9H12N5NaO4, and molecular weight 277.21 g/mol.
Procurement, formulation, quality, and regulatory teams should confirm the exact required API or salt form before commercial sourcing.
Swapnroop Drugs and Pharmaceuticals supports qualified pharmaceutical and research customers with:
Ganciclovir Sodium API is supplied in secure pharmaceutical-grade packaging selected according to product quantity, stability requirements, moisture protection requirements, and customer specifications.
Product-appropriate inner polyethylene liners and approved pharmaceutical-grade outer containers or HDPE drums may be used according to the supplied material specification.
Available packaging configurations may include:
Packaging configuration, MOQ, commercial quantity, formulation requirements, and shipment conditions are confirmed according to the approved product specification and customer enquiry.
Store Ganciclovir Sodium API in tightly closed and appropriately labeled containers under recommended controlled storage conditions.
Protect the material from excessive moisture, heat, direct light, and unsuitable environmental exposure.
Ganciclovir-related pharmaceutical materials require appropriate occupational handling controls. Handling should be performed by trained personnel using approved pharmaceutical material procedures, suitable containment practices, and applicable safety documentation.
Product-specific storage and handling requirements should be confirmed from the approved COA, SDS, specification, and stability documentation.
Swapnroop Drugs and Pharmaceuticals provides Ganciclovir Sodium API bulk supply and export support in India for qualified pharmaceutical manufacturers, injectable formulation developers, generic drug companies, antiviral pharmaceutical organizations, analytical laboratories, and pharmaceutical procurement customers.
Get Bulk Quote via WhatsApp